The following 3 stocks fared the worst amid Friday's decline

Markets closed lower, with Sarepta Therapeutics, Inc., Nektar Therapeutics, Bright Health Group Inc. making Friday's list of top losers.

A quick update: leading equity indices in the US declined as after dropping 1.19%, Dow Jones closed at 31,862. S&P 500 was down 1.1% before closing the session at 3,916.64.

In line with markets falling Friday, some healthcare stocks made the list of top losers. Take a look.

Sarepta | Closed Friday's session at $122.69

Having fallen $6.32 in 6 days, Friday's session continued down the same path: during Friday's session, Sarepta Therapeutics toiled and struggled for upward momentum before closing at $122.69. By the close, the the US biotech developer suffered a $26.98 or 18.03% loss.

Nektar Therapeutics ended the session at 98.01 cents, continuing its bearish run

More of the same from Friday's session: during Friday's session, Nektar Therapeutics toiled and struggled for upward momentum before closing at 98.01 cents. By the close, the the polymer conjugate technology developer suffered a 13.99 cents or 12.49% loss. Nektar Therapeutics has a market cap of $185.47 million with an average daily volume of 3.24 million shares.

-12.19%: bearish Bright Health declines 3.82 cents (12.19%)

Friday's session continued the recent downtrend: during Friday's session, Bright Health toiled and struggled for upward momentum before closing at 27.51 cents. By the close, the the US health insurance company suffered a 3.82 cents or 12.19% loss. Bright Health's market cap is currently $173.39 million with an average daily trading volume of 2.94 million shares. So far this year, it has been under-performing the Nasdaq by 43.92%.